- Title
- Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
- Creators
- Sabrina Paganoni - Spaulding Rehabilitation HospitalSuzanne Hendrix - TetraLogic Pharmaceuticals (United States)Samuel P. Dickson - TetraLogic Pharmaceuticals (United States)Newman Knowlton - TetraLogic Pharmaceuticals (United States)Eric A. Macklin - Harvard UniversityJames D. Berry - Clinical Research InstituteMichael A. Elliott - Swedish Medical CenterSamuel Maiser - Hennepin Healthcare Research InstituteChafic Karam - Oregon Health & Science UniversityJames B. Caress - Wake Forest UniversityJeremy M. Shefner - Barrow Neurological Instituteet al.
- Publication Details
- Muscle & nerve, Vol.63(1), pp.31-39
- Number of pages
- 9
- Grant note
- National Institute of Environmental Health Sciences (http://data.elsevier.com/vocabulary/SciValFunders/100000066) American Academy of Neurology (http://data.elsevier.com/vocabulary/SciValFunders/100005339) Cure Foundation Amyotrophic Lateral Sclerosis Association (http://data.elsevier.com/vocabulary/SciValFunders/100000971) Amylin Pharmaceuticals (http://data.elsevier.com/vocabulary/SciValFunders/100004323) Amyotrophic Lateral Sclerosis Association (100000971) Novartis (http://data.elsevier.com/vocabulary/SciValFunders/100004336) Fundação para a Ciência e a Tecnologia (http://data.elsevier.com/vocabulary/SciValFunders/501100001871) Ionis Pharmaceuticals (http://data.elsevier.com/vocabulary/SciValFunders/100013669) AANEM Foundation
- Identifiers
- 991006262207902656
- Academic Unit
- Neurology
- Language
- English
- Resource Type
- Journal article
Journal article
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
Muscle & nerve, Vol.63(1), pp.31-39
01/2021
PMID: 33063909
Metrics
1 Record Views